Literature DB >> 18462436

Gene expression profiling in the developing prostate.

Colin C Pritchard1, Peter S Nelson.   

Abstract

Gene expression profiling has proven to be an effective tool for characterizing genes and molecular pathways operative at key stages of organogenesis. Temporal profiling of RNA transcripts can provide valuable insights into mechanisms of differentiation and lay a foundation for characterizing molecular aspects of development. Descriptive and functional experiments have demonstrated critical roles for androgenic hormones and mesenchymal-epithelial interactions during prostate organogenesis. These studies have uncovered roles for members of several growth factor pathways--primarily using a candidate gene approach--but it is likely that critical molecular determinants of prostate organogenesis remain to be defined. Despite the potential for expression profiling to uncover novel genes and pathways, only a limited number of gene profiling studies have focused on the developing prostate. Among these are studies based on the generation of cDNA libraries and expressed sequence tags (ESTs) and other tag counting strategies such as serial analysis of gene expression (SAGE). Recently, microarray-based assays have provided more comprehensive time-course studies of molecular pathways associated with induction, branching morphogenesis, and secretory differentiation. Several profiling methods have also been used to characterize the influences of androgenic hormones on different tissue compartments including the urogenital sinus mesenchyme (UGM) and urogenital sinus epithelium (UGE) in order to define paracrine mediators operative in early morphogenesis. While hypothesis-driven candidate gene studies remain the gold standard for delineating cause-and-effect relationships dictating the complex biological regulators of the developing prostate, gene profiling provides a valuable adjunct, and is especially useful as an unbiased first step for generating new hypotheses. This review will focus on detailing the methods and results of profiling strategies in the context of normal prostate gland development, with implications for alterations in conserved pathways that may contribute to prostatic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462436     DOI: 10.1111/j.1432-0436.2008.00274.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  22 in total

1.  A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Authors:  Ji-An Liang; Li-Min Sun; Ming-Chia Lin; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Chia-Hung Kao
Journal:  Oncologist       Date:  2012-06-20

2.  PI3K/mTOR signaling regulates prostatic branching morphogenesis.

Authors:  Susmita Ghosh; Hiu Lau; Brian W Simons; Jonathan D Powell; David J Meyers; Angelo M De Marzo; David M Berman; Tamara L Lotan
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

3.  5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.

Authors:  C-H Chou; C-L Lin; M-C Lin; F-C Sung; C-H Kao
Journal:  J Endocrinol Invest       Date:  2015-03-17       Impact factor: 4.256

4.  Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer development.

Authors:  Ivan P Gorlov; Jinyoung Byun; Hongya Zhao; Christopher J Logothetis; Olga Y Gorlova
Journal:  J Bioinform Comput Biol       Date:  2012-04       Impact factor: 1.122

5.  Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.

Authors:  Jing Meng; Elahe A Mostaghel; Funda Vakar-Lopez; Bruce Montgomery; Larry True; Peter S Nelson
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

6.  Gene expression profiling during the byssogenesis of zebra mussel (Dreissena polymorpha).

Authors:  Wei Xu; Mohamed Faisal
Journal:  Mol Genet Genomics       Date:  2010-02-11       Impact factor: 3.291

7.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.

Authors:  Jonathan L Wright; Erika M Kwon; Elaine A Ostrander; R Bruce Montgomery; Daniel W Lin; Robert Vessella; Janet L Stanford; Elahe A Mostaghel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

8.  The role of Wnt5a in prostate gland development.

Authors:  Liwei Huang; Yongbing Pu; Wen Yang Hu; Lynn Birch; Douglas Luccio-Camelo; Terry Yamaguchi; Gail S Prins
Journal:  Dev Biol       Date:  2009-01-14       Impact factor: 3.582

Review 9.  Recent advances in prostate development and links to prostatic diseases.

Authors:  Ginny L Powers; Paul C Marker
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-01-17

10.  Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.

Authors:  Paula J Hurley; Luigi Marchionni; Brian W Simons; Ashley E Ross; Sarah B Peskoe; Rebecca M Miller; Nicholas Erho; Ismael A Vergara; Mercedeh Ghadessi; Zhenhua Huang; Bora Gurel; Ben Ho Park; Elai Davicioni; Robert B Jenkins; Elizabeth A Platz; David M Berman; Edward M Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.